Evaluation of LncRNAs As Potential Biomarkers for Diagnosis of Metastatic Triple-Negative Breast Cancer Through Bioinformatics and Machine Learning

Overview

Journal Iran J Biotechnol

Specialty Biotechnology

Date 2024 Dec 31

PMID 39737204

Authors

Shiva Soleimani

Farkhondeh Pouresmaeili

Iman Salahshoori Far

Affiliations

Soon will be listed here.

Abstract

Background: Triple-negative breast cancer (TNBC) is highly invasive and metastatic to the lymph nodes. Therefore, it is an urgent priority to distinguish novel biomarkers and molecular mechanisms of lymph node metastasis as the first step to the disease investigation. Long non-coding RNAs (lncRNAs) have widely been explored in cancer tumorigenesis, progression, and invasion.

Objectives: This study aimed to identify and evaluate lncRNAs in the signaling pathway of gene in both metastatic and non-metastatic TNBC samples. The potential of lncRNAs in prognosis and diagnosis of the disease was also assessed using bioinformatics analysis, machine learning, and quantitative real-time PCR.

Materials And Methods: Using machine learning algorithms, we analyzed the available BC data from the Cancer Genome Atlas Network (TCGA) and identified three potential lncRNAs, gastric adenocarcinoma-associated, positive CD44 regulator, long intergenic noncoding RNA (), , and antisense RNA 1 () that could successfully distinguish between metastatic and non-metastatic TNBC.

Results: The results showed the upregulation of lncRNA in metastatic BC tissues, compared to non-metastatic (P<0.01) and normal samples, though and were downregulated in metastatic TNBC samples (P<0.01).

Conclusion: Given the aberrant expression of candidate lncRNAs and the underlying mechanisms, the above-mentioned RNAs could act as novel diagnostic and prognostic biomarkers in metastatic BC.

References

Zaheed O, Samson J, Dean K . A bioinformatics approach to identify novel long, non-coding RNAs in breast cancer cell lines from an existing RNA-sequencing dataset. Noncoding RNA Res. 2020; 5(2):48-59. PMC: 7078458. DOI: 10.1016/j.ncrna.2020.02.004. View

Kothari C, Osseni M, Agbo L, Ouellette G, Deraspe M, Laviolette F . Machine learning analysis identifies genes differentiating triple negative breast cancers. Sci Rep. 2020; 10(1):10464. PMC: 7320018. DOI: 10.1038/s41598-020-67525-1. View

Zhang W, Shen Y, Huang H, Pan S, Jiang J, Chen W . A Rosetta Stone for Breast Cancer: Prognostic Value and Dynamic Regulation of Neutrophil in Tumor Microenvironment. Front Immunol. 2020; 11:1779. PMC: 7426521. DOI: 10.3389/fimmu.2020.01779. View

Jafarinejad-Farsangi S, Moazzam-Jazi M, Ghale-Noie Z, Askari N, Miri Karam Z, Mollazadeh S . Investigation of genes and pathways involved in breast cancer subtypes through gene expression meta-analysis. Gene. 2022; 821:146328. DOI: 10.1016/j.gene.2022.146328. View

Bridges M, Daulagala A, Kourtidis A . LNCcation: lncRNA localization and function. J Cell Biol. 2021; 220(2). PMC: 7816648. DOI: 10.1083/jcb.202009045. View

Arun G, Aggarwal D, Spector D . Long Non-Coding RNA: Functional Implications. Noncoding RNA. 2020; 6(2). PMC: 7344863. DOI: 10.3390/ncrna6020022. View

Yang P, Chen T, Xu Z, Zhu H, Wang J, He Z . Long noncoding RNA GAPLINC promotes invasion in colorectal cancer by targeting SNAI2 through binding with PSF and NONO. Oncotarget. 2016; 7(27):42183-42194. PMC: 5173126. DOI: 10.18632/oncotarget.9741. View

Zhang Y, Sun J, Qi Y, Wang Y, Ding Y, Wang K . Long non-coding RNA TPT1-AS1 promotes angiogenesis and metastasis of colorectal cancer through TPT1-AS1/NF90/VEGFA signaling pathway. Aging (Albany NY). 2020; 12(7):6191-6205. PMC: 7185097. DOI: 10.18632/aging.103016. View

Miller K, Nogueira L, Mariotto A, Rowland J, Yabroff K, Alfano C . Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019; 69(5):363-385. DOI: 10.3322/caac.21565. View

10.

Hu C, Hart S, Gnanaolivu R, Huang H, Lee K, Na J . A Population-Based Study of Genes Previously Implicated in Breast Cancer. N Engl J Med. 2021; 384(5):440-451. PMC: 8127622. DOI: 10.1056/NEJMoa2005936. View

11.

Brancaccio M, Giachino C, Iazzetta A, Cordone A, De Marino E, Affinito O . Integrated Bioinformatics Analysis Reveals Novel miRNA as Biomarkers Associated with Preeclampsia. Genes (Basel). 2022; 13(10). PMC: 9601722. DOI: 10.3390/genes13101781. View

12.

Quayle L, Spicer A, Ottewell P, Holen I . Transcriptomic Profiling Reveals Novel Candidate Genes and Signalling Programs in Breast Cancer Quiescence and Dormancy. Cancers (Basel). 2021; 13(16). PMC: 8392441. DOI: 10.3390/cancers13163922. View

13.

Gonzalez de Vega R, Clases D, Fernandez-Sanchez M, Eiro N, Gonzalez L, Vizoso F . MMP-11 as a biomarker for metastatic breast cancer by immunohistochemical-assisted imaging mass spectrometry. Anal Bioanal Chem. 2018; 411(3):639-646. DOI: 10.1007/s00216-018-1365-3. View

14.

Boere I, Lok C, Poortmans P, Koppert L, Painter R, Vd Heuvel-Eibrink M . Breast cancer during pregnancy: epidemiology, phenotypes, presentation during pregnancy and therapeutic modalities. Best Pract Res Clin Obstet Gynaecol. 2022; 82:46-59. DOI: 10.1016/j.bpobgyn.2022.05.001. View

15.

Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M . A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004; 351(27):2817-26. DOI: 10.1056/NEJMoa041588. View

16.

Honda M, Iima M, Kataoka M, Fukushima Y, Ota R, Ohashi A . Biomarkers Predictive of Distant Disease-free Survival Derived from Diffusion-weighted Imaging of Breast Cancer. Magn Reson Med Sci. 2022; 22(4):469-476. PMC: 10552669. DOI: 10.2463/mrms.mp.2022-0060. View

17.

Li H, Jin J, Xian J, Wang W . lncRNA TPT1‑AS1 knockdown inhibits liver cancer cell proliferation, migration and invasion. Mol Med Rep. 2021; 24(5). PMC: 8441979. DOI: 10.3892/mmr.2021.12422. View

18.

Colditz G, Kaphingst K, Hankinson S, Rosner B . Family history and risk of breast cancer: nurses' health study. Breast Cancer Res Treat. 2012; 133(3):1097-104. PMC: 3387322. DOI: 10.1007/s10549-012-1985-9. View

19.

Sui Y, Li S, Fu X, Zhao Z, Xing S . Bioinformatics analyses of combined databases identify shared differentially expressed genes in cancer and autoimmune disease. J Transl Med. 2023; 21(1):109. PMC: 9921081. DOI: 10.1186/s12967-023-03943-9. View

20.

Mavaddat N, Pharoah P, Michailidou K, Tyrer J, Brook M, Bolla M . Prediction of breast cancer risk based on profiling with common genetic variants. J Natl Cancer Inst. 2015; 107(5). PMC: 4754625. DOI: 10.1093/jnci/djv036. View